Article Text
PDF
Statistics from Altmetric.com
OpenUrlCrossRefPubMedWeb of Science
Q Do paroxetine and psychotherapy reduce recurrent episodes of depression in the elderly?
METHODS
Design:
Two by two randomised controlled trial (randomisation stratified by number of episodes, use of additional pharmacotherapy, and degree of cognitive impairment).
Allocation:
Unclear.
Blinding:
Double blinded (for drug treatment).
Follow up period:
Two years.
Setting:
A university based clinic, Pittsburgh, USA; 1999 to 2005.
Patients:
116 people (⩾70 years old) who achieved a recovery from major depression (DSM-IV and a score of ⩾15 on the Hamilton Rating Scale for Depression and ⩾17 on the Folstein Mini-Mental State Examination) with open label paroxetine (10 mg daily initially, titrated up to 40 mg daily if necessary) and psychotherapy. A recovery was defined as a Hamilton score of 0 to 10 for three consecutive weeks, …
Footnotes
For correspondence: Charles F Reynolds III, Western Psychiatric Institute and Clinic, 3811 O’Hara Street, Room E-1135, Pittsburgh, PA 15213, USA; reynoldscf{at}upmc.edu
Sources of funding: National Institute of Mental Health, the National Center for Minority Health and Health Disparities, GlaxoSmithKline.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.